Dr. Brendan Carvalho shares insights from a study comparing Accuro’s accuracy to other ultrasound devices for neuraxial anesthesia. He explains how both Accuro and larger ultrasound systems reliably predict the point of loss of resistance, particularly in patients with challenging anatomy, such as those with obesity, scoliosis, or previous spine surgery. Dr. Carvalho highlights Accuro’s key advantages, including its portability, 3D navigation, and unique skin-marking feature, which together enhance precision and usability in both clinical and teaching environments.
Recent Posts
- Up to 92% First-Attempt Success: How AI Quality Improvement Is Transforming Neuraxial Anesthesia
- How 63% Fewer Readmissions Start with Smarter Healthcare Efficiency and AI
- RIVANNA awarded $3 million CDMRP grant to develop military-optimized ultrasound guidance system for spinal interventions
- 10% Lower OR Costs: How Neuraxial Anesthesia Is Delivering Measurable Hospital Savings
- What is Neuraxial Anesthesia? A Data-Driven Look at a Key Pillar in Modern Healthcare